Cours Cytori Therapeutics Inc Nasdaq
Actions
US23283K1051
Recherche biotechnologique et médicale
CA 2024 * | 6,93 M 6,33 M | CA 2025 * | 2,87 M 2,62 M | Capitalisation | 16,73 M 15,29 M |
---|---|---|---|---|---|
Résultat net 2024 * | -17 M -15,53 M | Résultat net 2025 * | -31 M -28,33 M | VE / CA 2024 * | 2,42 x |
Trésorerie nette 2024 * | - 0 | Trésorerie nette 2025 * | - 0 | VE / CA 2025 * | 5,84 x |
PER 2024 * |
-0,97
x | PER 2025 * |
-0,78
x | Employés | - |
Rendement 2024 * |
-
| Rendement 2025 * |
-
| Flottant | 93,82% |
Dernier transcript sur Cytori Therapeutics Inc
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Marc Hedrick
CEO | Chief Executive Officer | 61 | 01/10/02 |
Andrew Sims
DFI | Director of Finance/CFO | 51 | 06/02/20 |
Pius Maliakal
CTO | Chief Tech/Sci/R&D Officer | - | 27/07/23 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Marc Hedrick
CEO | Chief Executive Officer | 61 | 01/10/02 |
Richard Hawkins
CHM | Chairman | 75 | 01/12/07 |
Robert Lenk
BRD | Director/Board Member | 75 | 01/03/20 |
Varia. 1 janv. | Capi. | |
---|---|---|
+58,97% | 55,07 Md | |
-1,93% | 41,79 Md | |
+44,42% | 40,22 Md | |
-8,29% | 28,17 Md | |
+11,95% | 26,28 Md | |
-20,83% | 18,93 Md | |
+6,73% | 13,03 Md | |
+28,25% | 12,26 Md | |
+25,06% | 12,21 Md |